Nachrichten und Videos - DAVITA INC.

DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call PR Newswire DENVER, April 17, 2024 DENVER , April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as...

DaVita Announces Dennis Pullin to its Board of Directors PR Newswire DENVER, April 10, 2024 DENVER , April 10, 2024 /PRNewswire/ -- DaVita Inc. today announced that its Board of Directors has appointed a new independent director, Dennis Pullin , to join the Board, effective April 10, 2024 . "We're pleased to welcome Dennis to DaVita's board," said Pamela Arway , independent chair of the DaVita Inc. Board of Directors. "Given his depth of experience within the healthcare system, we're excited...

The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On PR Newswire DENVER, March 11, 2024 Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month DENVER , March 11, 2024 /PRNewswire/ -- Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on...

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024 PR Newswire DENVER, March 8, 2024 DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024 , at 8:00 a.m. EDT . To view the live webcast, visit the Barclays...

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador PR Newswire DENVER, March 5, 2024 Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia , and its entry into Chile and Ecuador . The deal, which is...

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador PR Newswire DENVER, March 5, 2024 Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia , and its entry into Chile and Ecuador . The deal, which is...

DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador PR Newswire DENVER, March 5, 2024 Expansion would make DaVita the largest dialysis services provider in Latin America DENVER , March 5, 2024 /PRNewswire/ -- DaVita Inc (NYSE: DVA), a leading provider of kidney care services, today announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia , and its entry into Chile and Ecuador . The deal, which is...

DaVita Inc. to Participate in the TD Cowen's Health Care Conference 2024 PR Newswire DENVER, Feb. 29, 2024 DENVER , Feb. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason , will participate in a fireside chat with investors at TD Cowen's Health Care Conference 2024 on Monday, March 4, 2024 , at 11:10 a.m. EST . To view the live webcast, visit the TD Cowen page and...

DaVita Inc. 4th Quarter 2023 Results PR Newswire DENVER, Feb. 13, 2024 DENVER , Feb. 13, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2023 . "As we reflect on the past year, our 2023 financial performance highlighted the resilience of our business," said Javier Rodriguez , CEO of DaVita Inc. "The external challenges of recent years ultimately made us stronger, and with continued investment in our teammates,...

DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call PR Newswire DENVER, Jan. 23, 2024 DENVER , Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as...

DaVita Giving Foundation Invests $1 Million in Western Governors University to Support Nursing Students PR Newswire DENVER, Dec. 19, 2023 Funding to support co-created 'Start Early' program aimed at increasing degree completion rates DENVER , Dec. 19, 2023 /PRNewswire/ -- The DaVita Giving Foundation has awarded Western Governors University's (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in Start Early , a...

DaVita Inc. 3rd Quarter 2023 Results PR Newswire DENVER, Nov. 7, 2023 DENVER , Nov. 7, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023 . "We delivered another strong quarter," said Javier Rodriguez , CEO of DaVita Inc. "We began the year by making progress earlier than expected across many of our key operating priorities, and that momentum has continued into the third quarter. We have balanced a strong focus on...

DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting PR Newswire DENVER and PHILADELPHIA, Nov. 2, 2023 Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA , Nov. 2, 2023 /PRNewswire/ -- DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita Inc., is presenting the...

DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care PR Newswire SUNNYVALE, Calif., Oct. 18, 2023 Kidney care provider harnesses the power of Google Cloud's leading-edge infrastructure, AI, and analytics tools to help improve care plans and streamline clinical workflows SUNNYVALE, Calif. , Oct. 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) and Google Cloud today announced that the organizations have collaborated to create a...

DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call PR Newswire DENVER, Oct. 17, 2023 DENVER , Oct. 17, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as...

DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease PR Newswire DENVER, Oct. 12, 2023 DENVER , Oct. 12, 2023 /PRNewswire/ -- DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes, related to its FLOW study that sought to demonstrate that Ozempic delays progression of chronic kidney disease (CKD) and lowers the risk of kidney and...

DaVita launches community health tour to provide free kidney screenings and education coast-to-coast PR Newswire DENVER, Sept. 13, 2023 Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER , Sept. 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services, today announced the launch of its 2023 Health Tour, a mobile health screening and kidney care education...

DaVita and Adtalem collaborate to address growing nephrology nursing shortage PR Newswire DENVER, Sept. 12, 2023 Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER , Sept. 12, 2023 /PRNewswire/ -- DaVita Inc. , a leading kidney care provider, has joined forces with Adtalem Global Education, to launch the "Introduction to Nephrology Nursing" curriculum as a part of the Practice Ready. Specialty Focused. ™ (PRSF) initiative at...

DaVita Inc. to Participate in Fireside Chat with UBS PR Newswire DENVER, Sept. 11, 2023 DENVER , Sept. 11, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat hosted by UBS on Thursday, September 14, 2023 , at 11:30 am EDT . To view the live webcast, visit the UBS page here and create a free registration. About DaVita Inc. DaVita (NYSE:...

DaVita Inc. 2nd Quarter 2023 Results PR Newswire DENVER, Aug. 3, 2023 DENVER , Aug. 3, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2023. "Over the first half of the year, DaVita has been focused on innovation in our clinical systems and driving operational improvements throughout our organization," said Javier Rodriguez , CEO of DaVita Inc. "Our second quarter performance reflects strong traction across those initiatives,...